“…The impact on enhancing recovery and long-term outcomes must incorporate additional patient factors and selection criteria, optimal device utilization to include data on myocardial performance, duration and doses of inotropes [112], the stages of AKI [113], various ventilation tactics and timing, mobility, mortality, rescue and failure to rescue [114], ICU and total LOS, readmissions, as well as patient-reported outcomes [29,115,116 && ]. Areas of burgeoning interest and opportunity also include wearable technologies [117][118][119][120][121], novel digital technologies with intelligent computing algorithms [122], virtual ICUs (where the rare expertise with tMCS may be leveraged via technology) [123], discharge location [124], time at home, remote monitoring [125,126], and cardiac rehabilitation [127,128].…”